US stocks declined for a second day on
Wednesday, weighed down by tepid data on private sector US jobs and a retreat
in biotech shares.
Weaker-than-expected
results from Priceline added to the bearish tone. The Nasdaq Biotech Index .NBI
dropped 2.9 percent, its seventh session of losses out of the last eight.
For Free Trial & Join Services For All Segment Click Here
No comments:
Post a Comment